Stroke therapy awarded
RMIT University has been awarded more than $398,000 in funding for research investigating ways to limit brain injury and complications after strokes.
RMIT University has been awarded more than $398,000 in funding for research investigating ways to limit brain injury and complications after strokes.
The funding from the National Health and Medical Research Council (NHMRC) was announced this week in Canberra by Prime Minister Tony Abbott and NHMRC CEO, Professor Warwick Anderson.
RMIT’s Drs Alyson Miller and Sarah Spencer were awarded the funding for their research project, Investigation of a novel stroke therapy: Investigating a novel agent to limit brain injury and post stroke complications.
“Stroke is a leading cause of morbidity and mortality worldwide, but treatment options are still limited,” Dr Miller, lead chief investigator, said.
“The goal of our research project will be to examine the potential of new aagent to protect the brain against stroke and to also treat complications that typically occur after stroke, including infection and weight loss.”
Dr Miller anticipates the research will ultimately lead to the development of an effective stroke therapy.
Professor David Adams, RMIT Acting Deputy Vice-Chancellor, Research and Innovation, and Director of the RMIT Health Innovations Research Institute, said: “The funding of this important research reflects our commitment to outcomeoriented research that aims to improve health and well-being across society.”
NHMRC funding supports individuals and small teams of researchers undertaking biomedical, public health and health services research, in Australian universities, medical schools, hospitals and other research institutions.
